{"organizations": [], "uuid": "60d6e4a83edbfa9c82634d21e53d6c33cff537ec", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-avadel-pharmaceuticals-announces-p/brief-avadel-pharmaceuticals-announces-pricing-of-125-mln-4-50-pct-exchangeable-senior-notes-idUSASB0C5O9", "country": "US", "domain_rank": 408, "title": "BRIEF-Avadel Pharmaceuticals Announces Pricing Of $125 Mln 4.50 Pct Exchangeable Senior Notes", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.066, "site_type": "news", "published": "2018-02-14T21:31:00.000+02:00", "replies_count": 0, "uuid": "60d6e4a83edbfa9c82634d21e53d6c33cff537ec"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-avadel-pharmaceuticals-announces-p/brief-avadel-pharmaceuticals-announces-pricing-of-125-mln-4-50-pct-exchangeable-senior-notes-idUSASB0C5O9", "ord_in_thread": 0, "title": "BRIEF-Avadel Pharmaceuticals Announces Pricing Of $125 Mln 4.50 Pct Exchangeable Senior Notes", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "avadel pharmaceuticals plc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Avadel Pharmaceuticals Plc:\n* AVADEL PHARMACEUTICALS ANNOUNCES PRICING OF $125.0 MILLION 4.50% EXCHANGEABLE SENIOR NOTES DUE 2023\n* AVADEL PHARMACEUTICALS - 2023 NOTES WILL BE EXCHANGEABLE AT OPTION OF HOLDERS AT INITIAL EXCHANGE RATE OF 92.6956 ADSS/$1,000 PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T21:31:00.000+02:00", "crawled": "2018-02-15T20:25:02.002+02:00", "highlightTitle": ""}